Nomura Asset Management Co. Ltd. boosted its holdings in shares of CVS Health Corp (NYSE:CVS) by 11.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 411,831 shares of the pharmacy operator’s stock after purchasing an additional 40,962 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in CVS Health were worth $26,501,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in CVS. BlackRock Inc. increased its holdings in shares of CVS Health by 4.5% during the first quarter. BlackRock Inc. now owns 70,013,482 shares of the pharmacy operator’s stock worth $4,355,536,000 after buying an additional 3,016,972 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its holdings in shares of CVS Health by 16.7% during the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 18,102,755 shares of the pharmacy operator’s stock worth $1,126,173,000 after buying an additional 2,588,382 shares in the last quarter. Veritas Asset Management LLP increased its holdings in shares of CVS Health by 4.5% during the second quarter. Veritas Asset Management LLP now owns 11,890,424 shares of the pharmacy operator’s stock worth $765,149,000 after buying an additional 508,500 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of CVS Health by 2.2% during the fourth quarter. Geode Capital Management LLC now owns 10,868,331 shares of the pharmacy operator’s stock worth $786,322,000 after buying an additional 235,357 shares in the last quarter. Finally, Boston Partners increased its holdings in shares of CVS Health by 41.9% during the second quarter. Boston Partners now owns 9,908,888 shares of the pharmacy operator’s stock worth $637,637,000 after buying an additional 2,924,875 shares in the last quarter. Hedge funds and other institutional investors own 83.60% of the company’s stock.

Shares of CVS Health stock opened at $73.20 on Friday. The company has a debt-to-equity ratio of 1.73, a current ratio of 2.34 and a quick ratio of 1.87. The company has a market capitalization of $70.30 billion, a P/E ratio of 12.41, a P/E/G ratio of 0.93 and a beta of 0.96. CVS Health Corp has a fifty-two week low of $60.14 and a fifty-two week high of $84.00.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 8th. The pharmacy operator reported $1.69 earnings per share for the quarter, beating analysts’ consensus estimates of $1.61 by $0.08. The business had revenue of $46.71 billion during the quarter, compared to analyst estimates of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. CVS Health’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.33 earnings per share. equities analysts predict that CVS Health Corp will post 7.04 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 1st. Investors of record on Wednesday, July 25th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.73%. The ex-dividend date of this dividend was Tuesday, July 24th. CVS Health’s dividend payout ratio is currently 33.90%.

CVS has been the subject of several recent analyst reports. Loop Capital set a $68.00 price objective on shares of CVS Health and gave the stock a “hold” rating in a report on Monday, May 7th. ValuEngine lowered shares of CVS Health from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Mizuho set a $95.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a report on Wednesday, June 13th. Royal Bank of Canada dropped their price objective on shares of CVS Health to $84.00 and set an “outperform” rating for the company in a report on Friday, June 29th. Finally, Citigroup reaffirmed a “buy” rating and set a $81.00 price objective on shares of CVS Health in a report on Monday, July 9th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $86.04.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Story: Price to Earnings Ratio (PE) Basics

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.